Vigil Neuroscience, Inc. (VIGL)
Aug 5, 2025 - VIGL was delisted (reason: acquired by SNY)
8.05
0.00 (0.00%)
Inactive · Last trade price
on Aug 4, 2025
Vigil Neuroscience Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Cash & Equivalents | 41.21 | 39.02 | 51.99 | 186.61 | 91.42 | 24.15 |
| Short-Term Investments | 25.77 | 58.78 | 65.95 | - | - | - |
| Cash & Short-Term Investments | 66.99 | 97.8 | 117.94 | 186.61 | 91.42 | 24.15 |
| Cash Growth | -22.72% | -17.08% | -36.80% | 104.12% | 278.54% | - |
| Other Receivables | 0.56 | 0.6 | 1.49 | 0.02 | - | - |
| Receivables | 0.56 | 0.6 | 1.49 | 0.02 | - | - |
| Prepaid Expenses | 1.75 | 1.34 | 1.69 | 6.8 | 5.7 | 1.08 |
| Other Current Assets | 1 | 0.85 | 0.8 | 4.38 | 0.36 | 0.07 |
| Total Current Assets | 70.29 | 100.58 | 121.91 | 197.81 | 97.48 | 25.3 |
| Property, Plant & Equipment | 15.46 | 16.09 | 17.94 | 1.4 | 1.27 | - |
| Long-Term Deferred Charges | - | - | - | - | 2.76 | - |
| Other Long-Term Assets | 0.95 | 1.02 | 1.01 | 1.19 | 0.93 | - |
| Total Assets | 86.7 | 117.69 | 140.86 | 200.39 | 102.44 | 25.3 |
| Accounts Payable | 1.55 | 1.97 | 1.95 | 1.94 | 3.98 | 1.11 |
| Accrued Expenses | 8 | 10.85 | 8.49 | 7.39 | 4.37 | 0.87 |
| Current Portion of Leases | 1.11 | 1.04 | 0.91 | 0.18 | 0.87 | - |
| Current Unearned Revenue | 20.01 | 20.01 | - | - | - | - |
| Other Current Liabilities | 3.44 | 0.29 | 0.32 | 1.8 | 0.66 | 0.02 |
| Total Current Liabilities | 34.11 | 34.15 | 11.66 | 11.31 | 9.88 | 2 |
| Long-Term Debt | - | - | - | - | - | 0.3 |
| Long-Term Leases | 11.33 | 11.91 | 12.95 | - | 0.06 | - |
| Other Long-Term Liabilities | - | - | - | - | - | 4.25 |
| Total Liabilities | 45.44 | 46.06 | 24.61 | 11.31 | 9.95 | 6.55 |
| Common Stock | 0.01 | 0 | 0 | 0 | - | - |
| Additional Paid-In Capital | 397.35 | 378.63 | 339.03 | 329.21 | 2.39 | 0.26 |
| Retained Earnings | -356.1 | -307.03 | -222.77 | -140.13 | -71.83 | -28.55 |
| Comprehensive Income & Other | 0 | 0.03 | -0.01 | - | - | - |
| Total Common Equity | 41.26 | 71.64 | 116.25 | 189.08 | -69.44 | -28.28 |
| Shareholders' Equity | 41.26 | 71.64 | 116.25 | 189.08 | 92.5 | 18.75 |
| Total Liabilities & Equity | 86.7 | 117.69 | 140.86 | 200.39 | 102.44 | 25.3 |
| Total Debt | 12.44 | 12.95 | 13.85 | 0.18 | 0.94 | 0.3 |
| Net Cash (Debt) | 54.55 | 84.85 | 104.09 | 186.43 | 90.48 | 23.85 |
| Net Cash Growth | -25.55% | -18.48% | -44.17% | 106.04% | 279.42% | - |
| Net Cash Per Share | 1.24 | 2.09 | 2.69 | 5.88 | 59.07 | 17.67 |
| Filing Date Shares Outstanding | 47.7 | 46.67 | 36.88 | 35.64 | 28.27 | 1.75 |
| Total Common Shares Outstanding | 47.69 | 40.89 | 35.88 | 35.62 | 1.72 | 1.75 |
| Working Capital | 36.18 | 66.44 | 110.25 | 186.49 | 87.6 | 23.3 |
| Book Value Per Share | 0.87 | 1.75 | 3.24 | 5.31 | -40.26 | -16.17 |
| Tangible Book Value | 41.26 | 71.64 | 116.25 | 189.08 | -69.44 | -28.28 |
| Tangible Book Value Per Share | 0.87 | 1.75 | 3.24 | 5.31 | -40.26 | -16.17 |
| Machinery | - | 1.89 | 1.89 | 0.3 | 0.2 | - |
| Construction In Progress | - | - | - | 0.94 | 0.1 | - |
| Leasehold Improvements | - | 0.23 | 0.23 | - | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.